Randomized, Double-Blind, Placebo-Controlled Phase II Study of Single-Agent Oral Talactoferrin in Patients with Locally Advanced or Metastatic Non-Small-cell Lung Cancer That Progressed after Chemotherapy.
Journal of Clinical Oncology（2011）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined